HILT or Conventional Combined Physical Therapy, in the Management of Hemiplegic Shoulder Pain
High-intensity Laser Therapy (HILT) or Conventional Combined Physical Therapy in the Management of Hemiplegic Shoulder Pain ; Randomized Controlled Trial
1 other identifier
interventional
42
1 country
1
Brief Summary
Background: Hemiplegic shoulder pain is one of the most common complications after a stroke. There are many treatment strategies for this complication. High-intensity laser therapy (HILT) is a new treatment option, and we aimed to compare the effectiveness of conventional electrotherapy agents and HILT in this study. Patients and methods: Participants (N = 42) were randomized into the HILT (n = 21) and TENS+US (n = 21) groups. Group 1 received 3 sessions of HILT per week for 3 weeks in addition to a therapeutic exercise program that performed 5 sessions per week for 3 weeks. Group 2 received conventional physical therapy and a therapeutic exercise program for HSP of 5 sessions per week for 3 weeks. Patients were assessed before and after treatment on the on the 6th week for radiological evaluation with ultrasonography and for clinical parameters with VAS, AMAT, MRS, and FIQ scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedFirst Submitted
Initial submission to the registry
March 29, 2024
CompletedFirst Posted
Study publicly available on registry
May 9, 2024
CompletedMay 9, 2024
May 1, 2024
8 months
March 29, 2024
May 6, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
visual analog scale
pain level, between 0-10, 0 is no pain, 10 is very severe pain
before treatment(baseline), after treatment
arm motor ability test
this scale asses the upper extremity motor function improvement and daily living activity level , between 0 is the worst score, mean is cant do/use, 5 is the best score.(between 0-5)
before treatment(baseline), after treatment
functional indepandance measures
functional capacity assessment scale;and despite indepandance of daily living activity 0-126, high score is better function
before treatment(baseline), after treatment
modified ranking scale
determines the patient's addiction level and evaluates disability; the score is between 0 and 6, where 0 is complete well-being, 5 is very severe disorder and 6 is full dependency
before treatment(baseline), after treatment
Secondary Outcomes (1)
ultrasonographic imaging
before treatment(baseline), after treatment
Study Arms (2)
group 1: high intensive laser
EXPERIMENTALHILT was applied 3 times per week, totaling 9 sessions for three weeks.
group 2: TENS+Ultrasound
EXPERIMENTALtens+us used combined. 5 times per week. total 15 sessions for three weeks
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosed case of HSP,
- Age ≥18,
- First-ever unilateral stroke,
- Visual analog scale (VAS) ≥30 mm,
- Time since stroke ≥6 months,
- Time since last local intervention treatment \>6 months.
You may not qualify if:
- A history of shoulder pain prior to stroke;
- An unstable medical condition or uncontrolled systemic diseases (such as respiratory failure, congestive heart failure, liver and kidney dysfunction, or any other disorders affecting neuromuscular function);
- Bilateral hemiplegia;
- Cardiac pacemakers;
- Disturbance of awareness, severe visual and cognitive impairment, Mini-Mental State Examination score: \<23 points
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara City Hospital
Ankara, Çankaya, 06800, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2024
First Posted
May 9, 2024
Study Start
June 1, 2022
Primary Completion
February 1, 2023
Study Completion
August 30, 2023
Last Updated
May 9, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share